Skip to content
10-Q

Quarterly Report

Sigilon Therapeutics, Inc.

0001558370-22-017294

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 1, 2022 32.46M sh
Shares Diluted Q3 2022 · Sep 30, 2022 32.4M sh
Shares Diluted Q3 2022 · Sep 30, 2022 32.39M sh
Shares Diluted Q3 2022 · Sep 30, 2021 32.06M sh
Shares Diluted Q3 2022 · Sep 30, 2021 31.71M sh
Capex Q3 2022 · Sep 30, 2022 $512K
Capex Q3 2022 · Sep 30, 2021 $1.53M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$44.26M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$61.03M
Long Term Debt Q3 2022 · Sep 30, 2022 $13.62M
Long Term Debt Q3 2022 · Dec 31, 2021 $18.41M
Short Term Debt Q3 2022 · Sep 30, 2022 $6.67M
Short Term Debt Q3 2022 · Dec 31, 2021 $1.67M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $32.93M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $107.14M
Stockholders Equity Q3 2022 · Sep 30, 2022 $44.41M
Stockholders Equity Q3 2022 · Jun 30, 2022 $51.81M
Stockholders Equity Q3 2022 · Mar 31, 2022 $64.59M
Stockholders Equity Q3 2022 · Dec 31, 2021 $77.16M
Stockholders Equity Q3 2022 · Sep 30, 2021 $93.3M
Stockholders Equity Q3 2022 · Jun 30, 2021 $111.07M
Stockholders Equity Q3 2022 · Mar 31, 2021 $129.03M
Stockholders Equity Q3 2022 · Dec 31, 2020 $146.16M
Current Liabilities Q3 2022 · Sep 30, 2022 $30.56M
Current Liabilities Q3 2022 · Dec 31, 2021 $34.89M
Total Liabilities Q3 2022 · Sep 30, 2022 $50.21M
Total Liabilities Q3 2022 · Dec 31, 2021 $67.21M
Current Assets Q3 2022 · Sep 30, 2022 $80.63M
Current Assets Q3 2022 · Dec 31, 2021 $126.39M
Total Assets Q3 2022 · Sep 30, 2022 $94.62M
Total Assets Q3 2022 · Dec 31, 2021 $144.37M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.27
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.14
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.63
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.88
Eps Basic Q3 2022 · Sep 30, 2022 −$0.27
Eps Basic Q3 2022 · Sep 30, 2022 −$1.14
Eps Basic Q3 2022 · Sep 30, 2021 −$0.63
Eps Basic Q3 2022 · Sep 30, 2021 −$1.88
Sga Expense Q3 2022 · Sep 30, 2022 $4.4M
Sga Expense Q3 2022 · Sep 30, 2022 $14.46M
Sga Expense Q3 2022 · Sep 30, 2021 $5.04M
Sga Expense Q3 2022 · Sep 30, 2021 $15.57M
Rd Expense Q3 2022 · Sep 30, 2022 $8.28M
Rd Expense Q3 2022 · Sep 30, 2022 $31.78M
Rd Expense Q3 2022 · Sep 30, 2021 $16.65M
Rd Expense Q3 2022 · Sep 30, 2021 $50.38M
Net Income Q3 2022 · Sep 30, 2022 −$8.67M
Net Income Q3 2022 · Sep 30, 2022 −$36.88M
Net Income Q3 2022 · Jun 30, 2022 −$14.35M
Net Income Q3 2022 · Mar 31, 2022 −$13.86M
Net Income Q3 2022 · Dec 31, 2021 −$77.3M
Net Income Q3 2022 · Sep 30, 2021 −$20.16M
Net Income Q3 2022 · Sep 30, 2021 −$59.57M
Net Income Q3 2022 · Jun 30, 2021 −$20.44M
Net Income Q3 2022 · Mar 31, 2021 −$18.97M
Operating Income Q3 2022 · Sep 30, 2022 −$8.42M
Operating Income Q3 2022 · Sep 30, 2022 −$35.94M
Operating Income Q3 2022 · Sep 30, 2021 −$19.74M
Operating Income Q3 2022 · Sep 30, 2021 −$58.34M
Revenue Q3 2022 · Sep 30, 2022 $4.25M
Revenue Q3 2022 · Sep 30, 2022 $10.3M
Revenue Q3 2022 · Sep 30, 2021 $1.95M
Revenue Q3 2022 · Sep 30, 2021 $7.61M